Evidence map›Paper›PMID 32156722›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2020

Li-Fraumeni Exploration Consortium Data Coordinating Center: Building an Interactive Web-Based Resource for Collaborative International Cancer Epidemiology Research for a Rare Condition.

Phuong L Mai, Sharon R Sand, Neiladri Saha, Mauricio Oberti, Tom Dolafi, Lisa DiGianni, Elizabeth J Root, Xianhua Kong, Renee C Bremer, Karina M Santiago and 16 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 Status.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 13 institutions in 5 countries.

Phuong L MaiCenter for Medical Genetics and Genomics, University of Pittsburgh, Pittsburgh, Pennsylvania.ORCID 0000-0002-7486-4974
Sharon R SandCity of Hope National Medical Center, Duarte, California.
Neiladri SahaData Coordinating Center, ESAC, Inc., Rockville, Maryland.
Mauricio ObertiData Coordinating Center, ESAC, Inc., Rockville, Maryland.ORCID 0000-0001-7107-2616
Tom DolafiData Coordinating Center, ESAC, Inc., Rockville, Maryland.
Lisa DiGianniDana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Elizabeth J RootDana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Xianhua KongThe University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Renee C BremerDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Karina M SantiagoA.C. Camargo Cancer Center, São Paulo, Brazil.ORCID 0000-0002-6326-7795
Jasmina BojadzievaThe University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Derek BarleyGenomic Medicine, MAHSC, University of Manchester, Saint Mary's Hospital, Manchester, United Kingdom.
Ana NovokmetDivision of Hematology/Oncology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Karen A KetchumData Coordinating Center, ESAC, Inc., Rockville, Maryland.
Ngoc NguyenData Coordinating Center, ESAC, Inc., Rockville, Maryland.
Shine JacobData Coordinating Center, ESAC, Inc., Rockville, Maryland.ORCID 0000-0001-6559-8371
Kim E NicholsDivision of Cancer Predisposition, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-5581-6555
Christian P KratzDepartment of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
Joshua D SchiffmanHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah.ORCID 0000-0002-6968-7694
D Gareth EvansGenomic Medicine, MAHSC, University of Manchester, Saint Mary's Hospital, Manchester, United Kingdom.ORCID 0000-0002-8482-5784
Maria Isabel AchatzCentro de Oncologia, Hospital Sírio-Libanês, São Paulo, Brazil.
Louise C StrongDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.ORCID 0000-0001-6795-3744
Judy E GarberThe University of Texas M.D. Anderson Cancer Center, Houston, Texas.ORCID 0000-0001-9449-3982
Sweta A LadwaData Coordinating Center, ESAC, Inc., Rockville, Maryland.ORCID 0000-0002-3785-9543
David MalkinDivision of Hematology/Oncology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Jeffrey N WeitzelCity of Hope National Medical Center, Duarte, California. JWeitzel@coh.org.
The Coordinating Center · USThe University of Texas MD Anderson Cancer Center · USCity Of Hope National Medical Center · USDana-Farber Cancer Institute · USNational Cancer Institute · USSt Mary's Hospital · GBUniversity of Toronto · CAAC Camargo Hospital · BRHospital Sírio-Libanês · BRHuntsman Cancer Institute · USMedizinische Hochschule Hannover · DESt. Jude Children's Research Hospital · USUniversity of Pittsburgh Medical Center · US

Funding

Precision approaches to refining TP53-associated cancer riskR01CA242218 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI AMOS, CHRISTOPHER I., GARBER, JUDY E. · 2019 to 2023
$8.5M
NCI NIH HHS R01 CA242218
6 · The paper itself

Abstract

backgroundThe success of multisite collaborative research relies on effective data collection, harmonization, and aggregation strategies. Data Coordination Centers (DCC) serve to facilitate the implementation of these strategies. The utility of a DCC can be particularly relevant for research on rare diseases where collaboration from multiple sites to amass large aggregate datasets is essential. However, approaches to building a DCC have been scarcely documented.

methodsThe Li-Fraumeni Exploration (LiFE) Consortium's DCC was created using multiple open source packages, including LAM/G Application (Linux, Apache, MySQL, Grails), Extraction-Transformation-Loading (ETL) Pentaho Data Integration Tool, and the Saiku-Mondrian client. This document serves as a resource for building a rare disease DCC for multi-institutional collaborative research.

resultsThe primary scientific and technological objective to create an online central repository into which data from all participating sites could be deposited, harmonized, aggregated, disseminated, and analyzed was completed. The cohort now include 2,193 participants from six contributing sites, including 1,354 individuals from families with a pathogenic or likely variant in

conclusionsThe methods leveraged mitigate challenges associated with successfully developing a DCC's technical infrastructure, data harmonization efforts, communications, and software development and applications. IMPACT: These methods can serve as a framework in establishing other collaborative research efforts. Data from the consortium will serve as a great resource for collaborative research to improve knowledge on, and the ability to care for, individuals and families with Li-Fraumeni syndrome.

Indexed as

Health Information ExchangeInternational CooperationAdolescentAdultAgedAged, 80 and overChildChild, PreschoolCohort StudiesData CollectionFemaleGenetic Predisposition to DiseaseGerm-Line MutationGlobal Burden of DiseaseHumansInfantTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID32156722
PMCPMC7196512
OpenAlexW3011633931

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.